682803-13-0 Usage
Uses
Used in Pharmaceutical Synthesis:
3-amino-2-(4-methylbenzyl)propanoic acid is used as a building block for the synthesis of various pharmaceuticals and biologically active molecules. Its unique structure allows for the creation of new compounds with potential therapeutic applications.
Used in Drug Discovery and Development:
Due to its structural characteristics and pharmacological properties, 3-amino-2-(4-methylbenzyl)propanoic acid is used as a starting point in drug discovery and development. It may contribute to the identification of new drug candidates with novel mechanisms of action and therapeutic potential.
Used in Research and Development:
3-amino-2-(4-methylbenzyl)propanoic acid is utilized in research and development to understand its potential uses and effects. Further studies are necessary to fully explore its applications in various fields, including medicine, biology, and chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 682803-13-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,2,8,0 and 3 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 682803-13:
(8*6)+(7*8)+(6*2)+(5*8)+(4*0)+(3*3)+(2*1)+(1*3)=170
170 % 10 = 0
So 682803-13-0 is a valid CAS Registry Number.
682803-13-0Relevant articles and documents
Catalytic Asymmetric Synthesis of Unprotected β2-Amino Acids
Zhu, Chendan,Mandrelli, Francesca,Zhou, Hui,Maji, Rajat,List, Benjamin
, p. 3312 - 3317 (2021/04/07)
We report here a scalable, catalytic one-pot approach to enantiopure and unmodified β2-amino acids. A newly developed confined imidodiphosphorimidate (IDPi) catalyzes a broadly applicable reaction of diverse bis-silyl ketene acetals with a silylated aminomethyl ether, followed by hydrolytic workup, to give free β2-amino acids in high yields, purity, and enantioselectivity. Importantly, both aromatic and aliphatic β2-amino acids can be obtained using this method. Mechanistic studies are consistent with the aminomethylation to proceed via silylium-based asymmetric counteranion-directed catalysis (Si-ACDC) and a transition state to explain the enantioselectivity is suggested on the basis of density functional theory calculation.
